Although both FASN and FZD10 could independently predict the outcome of NPC patients, NPC patients lacking both FASN and FZD10 had the best OS when compared to other groups with different combinations of expression profiles of FASN and FZD10. The gene discussed is FZD10; the disease is nasopharyngeal carcinoma.